Amplification of the int-2 oncogene was measured in a series of breast tumours and related to amplification of the c-myc and c-erbB-2 oncogenes, histopathological features and relapse-free and overall survival. int-2 was amplified in I I%, c-myc in 20% and c-erbB-2 in 27% of the tumours assessed. in
INT2 and ERBB2 amplification and ERBB2 expression in breast tumors from patients with different outcomes
โ Scribed by Robert J. Pauley; Phyllis A. Gimotty; Terry J. Paine; Peter J. Dawson; Sandra R. Wolman
- Publisher
- Springer US
- Year
- 1996
- Tongue
- English
- Weight
- 971 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Ampliยฎcation of the c-erbB2 oncogene and numerical aberrations of chromosome 17 occur in human breast carcinomas. Apocrine adenosis (AA) of the breast has been shown occasionally to have c-erbB2 overexpression and a possible premalignant potential, but little is known about cellular level genetic al
We investigated c-erbB-2 oncogene amplification and overexpression in 79 invasive breast carcinoma samples using fluorescence in situ hybridization (FISH) and immunohistochemistry, with the aim of studying relationships between neoplasms over-expressing c-erbB-2 with or without amplification and bio
## BACKGROUND. This study was conducted to determine the prognostic significance of tumor angiogenesis, c-erbB2, epidermal growth factor receptor, Ki-67, and p53 for patients with nasopharyngeal carcinoma. ## METHODS. In this retrospective study, the authors retrieved clinical data and made imm